() (OTCMKTS:AUSAF) CEO Scott Dowty caught up with Proactive's Andrew Scott while in London to discuss the news that they're to merge with Folium Biosciences.
Under the merger plan Folium will become a wholly owned subsidiary of Australis -- which will be rebranded as Folium Biosciences and will carry on the current business of Folium.
CSE:AUSA
Market: CSE
Market Cap: $75.34 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Australis Capital Inc named herein, including the promotion by the Company of Australis Capital Inc in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
Full interview: Australis Capital merges Fintech and Cannabis with the...
Australis Capital (CSE:AUSA-OTCMKTS: AUSAF) CEO Scott Dowty sat down with Steve Darling from Proactive Investors to discuss the company making it easier for consumers with their cloud-based self-fulfillment platform for dispensaries using cocoon technology. Dowty also told Proactive...
on 10/30/2019
2 min read
Prev article
4 min read
